Phase 2 Prostate Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You must be 18 years of age or older
- You must be a Black or African American man with prostate cancer that is locally advanced, high risk, has come back (based on a PSA blood test), or has spread to other parts of the body
- You must currently be receiving, or be about to start, one of the specific treatments listed in this trial — these include hormone therapy injections (leuprolide or degarelix), chemotherapy (cabazitaxel), immunotherapy (pembrolizumab), or bone-strengthening treatments (zoledronic acid or denosumab), and at least one of these must be given by a nurse who comes to your home
- Your treatment must be an approved or officially recommended standard treatment for your type of prostate cancer
- You are expected to continue your current treatment for at least 18 weeks after joining (if on chemotherapy or immunotherapy) or at least 24 weeks (for all other treatments)
- You must live within the area served by the home health supplier for this trial
- You must be well enough to carry out most daily activities (your doctor will assess this using a standard health scale)
- You must be willing and able to follow the study plan, including completing questionnaires (with help if needed)
- You must be willing to follow birth control requirements if you are able to father children
- You must be able to give written consent to participate
Who may not be able to join:
- You are currently taking part in another clinical trial that involves a treatment for your cancer
- You are currently staying in hospital as an inpatient (unless you are enrolled in a specific "Advanced Care at Home" programme)
- You have other serious ongoing health conditions that your doctor believes would make it unsafe or unsuitable for you to take part
- You have uncontrolled health problems such as an active infection, serious heart failure, unstable chest pain, an irregular heartbeat, a heart attack within the last 6 months, a wound that is not healing, or a mental health or personal situation that would make it hard to follow the study requirements
- You had a severe infection — including hospitalisation due to an infection, or a suspected or confirmed COVID-19 infection — within the 4 weeks before joining
- You are expected to need major surgery at any point during the trial (note: radiation therapy during the trial is allowed)
- You did not pass the home safety and social stability screening required before receiving treatment at home
- You previously received at-home treatment as part of another trial run by the same research group (CCBW) — though if you joined such a trial but never actually started home treatment, you may still be eligible (confirm with trial site)
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Roxana S. Dronca, MD, Mayo Clinic
Phone: 855-776-0015
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Patient rating of overall cancer care experience - CAHPS; Patient preferences regarding the location of cancer treatment delivery; Incidence of grade 3+ adverse events (AEs); Acute care visits, emergency room visits, and hospitalizations; Avoidable acute care visits, emergency room visits and hospitalizations
Can't join this trial?
Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.